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ABSTRACT
GoaI of work (key words): The use of polymer nano particles (NPs) is of potential interest in
the field of targeted drug delivery systems owing to multiple degrees of freedom like
bio-degradability, hydrophobicity and the form (particles, capsules) in which they can be
produced. The overall goal was to synthesize and characterize stable, monodisperse polymeric
NPs loaded with drugs using flash nanoprecipitation in a Multi Inlet Vortex Mixer (MIVM)
which could be used subsequently to build nano-clusters (NCs) comprising different drugs. The
work further aimed at studying and optimizing drug encapsulation, loading and release kinetics
from the synthesized NPs for different polymers.
Conclusions and recommendations (key words): The MIVM setup is found to produce stable
polymeric NPs as small as 50nm and as large as 155nm depending on polymer concentration
and nature of polymer. The results indicate that this setup is capable of producing
drug(ibuprofen) loaded NPs with high drug loading efficiencies varying betweenT5Yo and 88%
differing with polymers. This has been established to be both reproducible and valid for a wide
range of polymers (PLA, PLGA, PCL functionalized with different groups and their blends).
On the contraryo the release kinetics from almost all the different types of polymeric systems is
slow; lasting over several days and moreover, it is not possible to release the entire loaded drug.
It is claimed that either the chemical interaction of the polymers with ibuprofen or the location
of the drug inside the polymeric NPs is the potential reason for extremely slow release kinetics.
It is therefore suggested that further investigation is needed for the same system with another
drug to confirm the observed behavior or even a completely different synthesis method for drug
loaded polymeric NPs using ibuprofen to substantiate the observed results.
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of the Norwegian University of Science and Technology
Date and signature:
  
 
 
 
 
 
 
 
 
 
 
 
1 
 
Contents 
 
Abstract ......................................................................................................................................4 
1 Introduction .........................................................................................................................6 
2 Materials and Methods .........................................................................................................9 
2.1 Polymer synthesis and characterization .............................................................................9 
2.2 Synthesis and Characterization of Polymer NPs .............................................................. 10 
2.3 Synthesis of drug loaded polymer NPs: Drug Loading and encapsulation efficiencies ...... 13 
2.4 Drug Release Kinetics .................................................................................................... 14 
3 Results and Discussion ....................................................................................................... 16 
3.1 Characterization of PLA – Size Exclusion Chromatography (SEC) ................................. 16 
3.2 Size and Zeta Potential of synthesized NPs ..................................................................... 16 
3.3 Drug loading and Encapsulation efficiencies................................................................... 21 
3.4 In vitro release measurements ......................................................................................... 26 
4 Future Work ................................................................................................................... 32 
5 Conclusion ..................................................................................................................... 34 
6 Bibliography................................................................................................................... 36 
 
 
 
 
 
 
 
 
 
2 
 
List of Figures 
 
Figure 1  Schematic description of the formation mechanism of PLA NPs by the emulsification-
diffusion method based on the diffusion stranding mechanism[16] ............................................ 11 
Figure 2  (a) Experimental set-up for flash nanoprecipitation (b) Mixing chamber of Multi-Inlet-    
Vortex-Mixer. ........................................................................................................................... 12 
Figure 3 Calibration curve for determination of MW of polymers using SEC ............................ 16 
Figure 4 Plot of DLS Size (nm) of polymeric NPs vs concentration ........................................... 17 
Figure 5 Plot of Size (nm) of PLA NPs vs concentration ........................................................... 18 
Figure 6 Plot of Zeta potential(mV) of Polymeric NPs vs concentration .................................... 19 
Figure 7 Plot of Zeta potential (mV) of PLA NPs vs concentration ............................................ 20 
Figure 8 HPLC Calibration curve for ibuprofen ......................................................................... 21 
Figure 9 Comparison of chromatograms .................................................................................... 22 
Figure 10 Comparison of drug loading efficiencies (%) of polymeric NPs at 25°C .................... 24 
Figure 11 Comparison of encapsulation efficiencies (%) of polymeric NPs at 25°C .................. 25 
Figure 12 Comparison of Ibuprofen release kinetics from various PLA NPs and effect of 
temperature on release kinetics. ................................................................................................. 27 
Figure 13 Comparison of Ibuprofen release kinetics from (a) PCL-COOH NPs at different 
temperatures (b) various PCL NPs at room temperature ............................................................ 28 
Figure 14 Comparison of Ibuprofen release kinetics from various Polymeric NPs and Polymeric 
nano capsules ............................................................................................................................ 30 
Figure 15 Schematic of synthesis of NCs composed of two drugs.............................................. 33 
 
 
 
 
 
 
3 
 
Acknowledgement 
 
I express my profound gratitude and indebtedness to my external supervisors, Dr. Miroslav Soos 
and Prof Massimo Morbidelli, Institute for Chemical Bioengineering, ETH for their constant 
scientific supervision and valuable research guidance. This small endeavour would not have seen 
the light of the day without their constant scientific supports in various capacities.  
I would also like to extend my whole-hearted thanks and gratitude to my supervisor in Norway, 
Dr. Wilhelm Robert Glomm, Department of Chemical Engineering, NTNU for his ubiquitous 
scientific support at all levels of the project. 
I would like to sincerely thank Fabio, Martin, Bertrand, Stefano, David, Thomas, Monica 
(PhD students) and other members of the Morbidelli group for their advisory inputs at various 
stages of the work, and even more, for creating a friendly atmosphere. My special thanks to 
Jason for his invaluable help with the ultracentrifugation setup.  
My heartfelt thanks goes to all friends in Zurich, Norway and India who have extended their 
supports in various forms and at various junctures during this project.  
My vote of thanks also goes to my parents, who have been the pillars of my success in all that I 
have achieved so far. Without their continuous moral and educational support, the work would 
have just remained in pen and paper. I thank all my family members who have always stood by 
my side during the different phases of my life.  
I do extend my sincere thanks to my brother Ameen (PhD at Dept. of Telematics, NTNU) for his 
constant advisory support throughout the course of work.  
Finally, I must thank God for having given me the strength and blessings for making this attempt 
a fruitful one. 
 
 
 
4 
 
Abstract 
 
The use of polymer particles as tailored drug delivery systems is becoming more and more 
attractive. The reason for such growing interest is related to the many degrees of freedom which 
polymer materials offer (biodegradable vs non-degradable polymers, hydrophobic vs. 
hydrophillic) as well as the form in which they can be produced (particles, capsules). Even 
though this approach was successfully applied for producing particles containing single drug, the 
situation becomes much more complicated when several drugs should be delivered at the same 
time or when drug in combination with imaging agent would be of interest. In this case newly 
developed nano-clusters (NCs) can serve as a delivery device. In particular, such NCs are 
composed of many small nano-particles (NPs) loaded with different drugs, which can be 
prepared independently and combined thereafter. NCs can be efficiently produced through 
aggregation followed by breakup, or self-assembly of oppositely charged NPs, or aggregation 
driven by polyelectrolyte. To ensure biocompatibility of the produced NCs, primary particles 
need to be produced out of biodegradable polymer. In order to synthesize stable, multifunctional 
NCs loaded with several drugs; the constituent primary NPs have to be stable and show 
considerably fast release kinetics. 
The master thesis has investigated primarily on the synthesis of different polymeric NPs viz PLA 
(synthesized in house as well as commercial grade), PLGA (commercial) and PCL(synthesized 
in house, having different functionalities –COOH, -PEG and their blends) employing flash nano-
precipitation technique in a multi inlet vortex mixer (MIVM), previously optimized in the 
Morbidelli group at ETH. These NPs were characterized using DLS (Dynamic Light Scattering) 
and Zeta-Sizer to report the variation of the sizes and zeta potentials respectively of the NPs as a 
function of polymer molecular weight and initial concentration of polymer. The lowest possible 
sizes of the NPs were then selected for further studies as the overall motivation of the work is to 
synthesize NCs composed of primary particles and thereafter compare and contrast drug loading, 
encapsulation efficiencies and release kinetics of a model drug between the two. Ibuprofen 
(model drug) was loaded into the primary NPs using the MIVM setup, following which drug 
loading and encapsulation efficiencies were measured using High Performance Liquid 
Chromatography (HPLC). The release kinetics experiments were performed at 37°C and also 
studied at room temperature (25°C) and 45°C to evaluate the effect of temperature on release 
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mechanism. The drug-loaded NPs were separated from the free drug in solution at different times 
using centrifugal filtration. The amount of drug released over time was measured by analyzing 
these supernatants using HPLC.  
The MIVM setup is found to produce stable polymeric NPs as small as 50nm and as large as 
155nm depending on polymer concentration and nature of polymer. The results indicate that this 
setup is capable of producing drug loaded NPs with high drug loading efficiencies varying 
between 75% and 88% differing with polymers. This particular aspect has been established to be 
both reproducible and valid for a wide range of polymers through subsequent experiments. On 
the contrary, the release kinetics from almost all the different types of polymeric systems is slow; 
lasting over several days and moreover, it is not possible to release the entire loaded drug. It is 
claimed that either the chemical interaction of the polymers with ibuprofen or the location of the 
drug inside the polymeric NPs is the potential reason for extremely slow release kinetics. It is 
therefore suggested that further investigation is needed for the same system with another drug, 
having similar solubility parameters as ibuprofen to confirm the observed behaviour or even a 
completely different synthesis method for drug loaded polymeric NPs using ibuprofen to 
substantiate the observed results.   
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1 Introduction 
Targeted drug delivery and controlled release processes have become important and 
popular in medical science because it becomes possible to transport hydrophobic low 
molecular weight drugs, to enhance the efficiency of drugs and cure diseases like cancer 
or tumor faster than before. Due to the large variety of surface functionalities that NPs can 
possess, they are widely being used in health care and biomedicine, as clinical imaging 
agents and pharmaceutical delivery carriers. 
The design and development of bio-degradable carriers containing biologically active 
agents like drugs for therapeutic application require not only a fundamental understanding 
of the in vivo bio-degradation phenomena but also of cellular and tissue responses which 
determine the biocompatibility of the constructs [1]. The use of biodegradable polymers is 
very attractive because controlled drug release can not only be optimized by suitable 
degradation strategie but it also allows clearance of the polymeric material from the body, 
avoiding its accumulation and possible toxicity [2][3]. Polymers like poly (DL-lactic 
acid), poly-(L-lactic acid) and poly (lactide-co-glycolide) are just few examples that are 
widely used in drug delivery applications. In most cases, the drug carriers are synthesized 
in the form of micro-spheres. Macrophages are capable of phagocytosing very small 
particles (< 5 μm) while larger particle sizes (> 10 μm) induce the formation of foreign 
body giant cells [4]. Particles larger than 200 nm are sequestered by phagocytotic cells of 
the spleen, while particles smaller than 5.5 nm are rapidly removed through renal 
clearance [5]. Thus, ideally most drug delivery constructs need to be size-optimized 
between 10nm and 200nm to avoid both macrophages and foreign body giant cells.   
Bio-degradation mainly occurs through a homogeneous hydrolytic chain cleavage 
mechanism as reported by Vert et al [6]. The rates of polymer degradation are the same for 
the bulk and surface of the drug carriers, however, it is affected by their size, the nature of 
the drug incorporated, the molecular weight and molecular weight distribution of the 
polymer [7]. On the other hand, bio-compatibility of the drug delivery systems is 
explained based on inflammation, wound healing and foreign body responses [1].   
Colloidal drug delivery is advantageous in many ways as it can deliver poorly water-
soluble drug molecules, settle stability issues typical of biological drug molecules, design 
7 
 
parenteral sustained release forms and provide functionalized soft particles that are very 
effective in drug targeting [8]. Further, these also act as continuous sources of drugs, 
therefore supplying the subject with a continuous dose as opposed to sudden variations in 
concentration as injection or pills do. It is a regular practice to incorporate multiple 
functionalities in NPs to achieve various goals. For example, core-shell NPs are widely 
used in the field of medical diagnostics and drug delivery as multimodal agents uniting 
various functionalities like contrasting, targeting, imaging into a single nano-structured 
system. 
On the other hand, the use of NCs has found large attention in the production of sensors 
and microelectronics as well as in cellular imaging and therapy due to particles’ 
segregation and enhancement of functionality, such as the enhanced absorbance used in 
biomedical imaging and therapy [9]. In principle, there exist two strategies for NC 
preparation, viz thermodynamically-driven self assembly and kinetically-driven self 
assembly of primary particles. Thermodynamic self assembly is achieved through specific 
interactions between NPs and templating agents like polymers and is also affected by 
parameters that affect self-assembly like temperature, pH and ionic strength [10]. Owing 
to the fact that large amounts of these agents are retained in the NCs, the metal loading is 
substantially reduced [11]. The size of the NCs is thus exclusively controlled by specific 
interactions due to surface/bulk properties until a minimum energy configuration is 
reached.  On the other hand, kinetic self-assembly is obtained through the manipulation of 
Van der Waal’s and electrostatic interactions, by varying solution’s pH or ionic strength, 
and steric interactions between particles [11]. In this case, the aggregation process is 
stopped by the addition of a stabilizer. Since aggregation is intrinsically a function of the 
NP surface and nature, NC size is highly controlled knowing the aggregation kinetics [12]. 
However, the main drawback is uncontrolled growth that often yields irregularly shaped 
aggregates greater than several hundred nanometers in diameter owing to rather open 
structure [11].  
The overall goal of this work was to synthesize and characterize stable, monodisperse 
polymeric NPs loaded with drugs using flash nanoprecipitation in a MIVM setup which 
could be used subsequently to build NCs comprising different drugs. The work aimed at 
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studying and optimizing drug encapsulation, loading and release kinetics from the 
synthesized NPs for different polymers.  
The subsequent chapters describe the techniques used for synthesizing polymeric NPs, 
polymeric NPs loaded with model drug ibuprofen, characterizing these synthesized drug- 
free and drug loaded polymeric NPs, measuring drug loading and encapsulation 
efficiencies and release kinetics in the same chronological order. Furthermore, different 
modifications of the parent process are also discussed in the light of the observed effects 
and recommendations are drawn for future work to achieve the overall aim of the project. 
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2 Materials and Methods 
2.1 Polymer synthesis and characterization 
For the poly-(DL-lactic acid) synthesis (hereafter referred to as PLA), DL lactide was 
purchased from PURAC (The Netherlands), initiator DL-lactic acid from Fluka 
(purity ~90%) and catalyst 2-Ethylhexanoic acid tin (II) salt (Sn(Oct)2 ,95% purity) 
from Sigma Aldrich. The solvents THF, toluene and dichloromethane, were 
purchased from Sigma Aldrich. 
PLA samples were synthesized in bulk by ring opening polymerization (ROP) of DL 
lactide catalyzed by SnOct2 and initiated by DL lactic acid. Since ROP of lactide is a 
semi-living process characterized by reversible catalyst activation, samples with 
different molecular weights are obtained by varying the catalyst to co-catalyst ratio 
[13]. Briefly, 25 g of lactide were melted at 130 °C in a closed 50 ml glass flask. The 
temperature was controlled by means of an external oil bath. Then, 0.07 g of catalyst 
and 0.034g of co-catalyst (initiator) were added and the reaction was carried out 
overnight. The polymer was finally purified by dissolution in 25ml of 
dichloromethane, followed by drop-wise addition of the same in excess of methanol 
resulting in precipitation of the polymer; in order to remove species with lower 
molecular weights such as residual monomer, impurities and reaction side products 
[14]. 
The molecular weight distributions were characterized by Size Exclusion 
Chromatography (SEC Agilent, 1100 series) equipped with two detectors; ultraviolet 
and differential refractive index. An oligopore column (Polymer Laboratories; length, 
300 mm; diameter, 7.5 mm; measuring range, 0 - 4500 Da) was used. Chloroform 
was used as eluent at a flow rate of 1 mL/min and at temperature of 30°C. The 
column was previously calibrated in the group with Polystyrene standard. PLA was 
dissolved in chloroform to make a concentration of 1mg/ml. This sample was injected 
into the SEC setup for analysis of the MW. The molecular weights are reported in 
Section 3.1 and are relative to poly (styrene) standards. 
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Besides PLA, other polymers have been used for the purpose of comparing and 
contrasting the drug loading, drug encapsulation and drug release kinetics 
measurements. Poly(lactic-co-glycolic acid) (PLGA), Polycaprolactone (PCL) 
functionalized with  COOH (PCL-COOH) and Poly(epsilon-caprolactone)-co-
poly(ethylene glycol) (PCL-MPEG) and a blend of  the two (PCL-COOH/MPEG) 
with a PEG ratio of 0.25 have been used in order to study the drug loading, 
encapsulation and release kinetics from individual polymeric NPs.  
As mentioned earlier, PLA was synthesized in-house while another grade of PLA 
(referred hence forth as PLA_SA, Mw 18kDa-24kDa) was purchased from Aldrich. 
PLGA (referred hence forth as PLGA_SA, acid terminated, 65:35, Mw                          
24kDa-38kDa) was also purchased from Adrich. The PCL polymers were used from 
samples synthesized previously in the group. 
2.2 Synthesis and Characterization of Polymer NPs 
As highlighted before, bio-degradable nano-spheres forms the most common form 
used in bio-medical applications. To produce spherical polymer NPs, there exist two 
different methods, the Emulsification-Diffusion method and the Solvent-
Displacement method.  
 
The Emulsification-Diffusion process [15] involves the formation of oil in water 
(o/w) emulsion with a partially water-soluble solvent, which contains the 
biodegradable polymer, and with an aqueous phase containing a stabilizer. The 
subsequent addition of water to the system causes the diffusion of the solvent into the 
external phase carrying with it some polymer and thus forming a three-component 
phase in the immediate vicinity of the interface. As the solvent diffuses further into 
the water, the associated polymer is thrown out of solution, and is "stranded" in the 
water in the form of fine emulsion drops. Thus, this “diffusion-stranding” mechanism 
explains the formation of NPs owing to solvent diffusion thereby producing regions 
of local super-saturation from which NPs are formed due to phase transformation in 
these regions [16].  
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Figure 1  Schematic description of the formation mechanism of PLA NPs by the       
emulsification-diffusion method based on the diffusion stranding mechanism[16] 
The solvent displacement method or nano-precipitation is in contrast a one step 
method and requires only two phases, a solvent and an anti-solvent phase. The 
solvent phase, usually organic includes the polymer, whereas the anti-solvent phase is 
usually water and if necessary a surfactant. The particle formation occurs due to 
interfacial turbulence or spontaneous agitation of the interface between two             
non-equilibrated liquid phases [17].However it is difficult to produce very small 
organic particles with direct nanoprecipitation.  
To produce organic NPs of small size and narrow particle size distribution flash nano-
precipitation (FNP) in a static mixer using a confined impinging jets (CIJ) mixer is a 
reported process [18]. The principle underlying the process is the rapid mixing of 
solvent and anti-solvent at a time-scale shorter than the formation time of the NP. 
Hence the mixing time τmix must be less than the induction polymer aggregation time 
τagg and the induction time for nucleation and growth τng. Mixing in milliseconds 
ensures that the NP properties depend on the kinetics of polymer aggregation and 
organic solute nucleation and growth [9]. So in FNP, kinetics instead of 
thermodynamics, controls the preparation of NPs and leads to a narrow particle size 
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distribution and the possibility of high drug loading. Later on a new design namely 
the multi-inlet vortex mixer (MIVM) was presented which enables to control the 
solvent/anti-solvent input ratio. With the MIVM, NPs of 50-500 nm with narrow size 
distribution can be produced due to rapid micro-mixing and high super-saturation 
values [10]. 
 
Polymer solutions containing 0.1 to 0.75 % by weight of polymer dissolved in THF 
were prepared. To precipitate the NPs in the MIVM, the prepared organic solutions 
were injected at a flow rate of 10 ml/min. The polymer solution was filtered before 
entering the mixer by passing through a CHROMAFIL Xtra PTFE-45 µm filter to 
remove any undissolved impurities. The water flow rate was set to 100 ml/min. The 
whole set up is shown in Figure 2. The system was allowed to equilibrate for 30 
seconds before withdrawing samples. In the initial phase of the research work, PLA 
was the polymer of utmost concern, however, the same process was employed for all 
the other polymers viz. PLA-HMW (MW 60kDa , synthesized in the group), PCL, 
PCL-COOH, PCL-MPEG, blends of PCL-COOH and PCL-MPEG, PLA_SA and 
PLGA_SA to synthesize respective polymeric NPs. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2  (a) Experimental set-up for flash nanoprecipitation (b) Mixing chamber  
of Multi-Inlet-Vortex-Mixer. 
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2.3 Synthesis of drug loaded polymer NPs: Drug Loading and 
Encapsulation Efficiencies 
In order to study drug encapsulation efficiency and release kinetics from NPs, model 
drug - Ibuprofen  was purchased from Sigma Aldrich. Ibuprofen is a non-steroid drug 
commonly used in the treatment of post-operative, epidural, arthritis, arthragra, 
dysmenorrhea and dental pain. It is an α-aryl propionic acid drug, shows poor water 
dissolution and tableting behaviour due to its hydrophobic substituted isobutyl 
benzene [19]. 
In order to maintain the composition of the drug (ibuprofen, in this case) in the water 
phase below the drug’s solubility limit, calculated amounts of ibuprofen were added 
to the polymer solution in THF (Table 1). The MIVM setup described in Section 
2.3.1 was used to synthesize PLA NPs loaded with ibuprofen, the only change made 
being the organic phase, which now contained both the polymer and the drug. 
Sample name Concn of PLA 
(wt %) 
Concn. of Ibuprofen   
(wt of drug/wt. of 
polymer) 
PLA0.1ibu1 0.10 0.010 
PLA0.1ibu5 0.10 0.050 
PLA0.1ibu25 0.10 0.250 
PLA0.1ibu125 0.10 1.250 
PLA0.75ibu1 0.75 0.001 
PLA0.75ibu5 0.75 0.007
 
PLA0.75ibu25 0.75 0.030 
PLA0.75ibu125 0.75 0.170 
Table 1 Composition of Ibuprofen in drug loaded PLA NPs 
These samples were prepared in order to study the drug loading efficiencies (LE) 
given by equation 2.1 and encapsulation efficiencies (EE) given by equation 2.2. 
                                                                                                                               (2.1)              
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(2.2) 
In order to calculate LE and EE values, centrifugal filtration was employed after THF 
removal in a rotary evaporator and the supernatant was analyzed thereafter using 
HPLC. The technique is detailed in the following sub-section, it being the same used 
for measuring the drug release kinetics.                                          
These drug loading and encapsulation results are presented in Section 3.3. However, 
it was observed that in cases of drug concentrations more than 0.05 g of drug per g of 
polymer, drug particles were formed (inferred from DLS results). Thus, the drug 
concentration was optimized at 0.05 g/g of polymer, as for lower concentrations, 
errors in weighing accurate drug amounts and detection (HPLC technique) on further 
dilution would have become problematic. 
2.4 Drug Release Kinetics 
The release experiments were carried out at room temperature using water as the 
release medium. The polymeric NPs loaded with drug were synthesized by the 
methods described above. The final solution was diluted ten times with water to 
provide a high enough concentration gradient for the drug release. From this stock 
solution, 500µl of solution was withdrawn at defined time intervals. The sample 
solution was filtered using Vivaspin centrifugal filters having a molecular weight cut 
off (MWCO) of 100K at 10,000rpm for 10 minutes. Thereafter, the supernatant was 
analyzed using HPLC. The HPLC used was an Agilent Technologies 1200 series. An 
Eclipse XDB-c18 column was used, with 5µm pore diameter and dimensions 4.6 x 
150mm (diameter x length). The eluent used was a mixture of THF (90% THF and 
10% distilled water by volume) and distilled water, both stabilized with phosphoric 
acid at pH 2.1. The flowrate used was 1ml/min. The eluent composition was changed 
in time: linearly from a 0vol% mixture of THF and water to 50vol% THF during the 
first 10 minutes, then maintained at the same condition for 5 minutes and then 
changed to 100vol% THF during the last 10 minutes.  
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Calibration curve was prepared for ibuprofen dissolved in THF. The calibration curve 
was used to calculate the concentration of the drug in the supernatant. The area under 
the curve at the drug elution time is a measure of the concentration of the drug in the 
solution, the calibration curve giving the constant showing relation between the moles 
of drug and the area. The results are enumerated subsequently in Sections 3.3 and 3.4. 
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3 Results and Discussion 
 
This section follows the same chronology as used in the previous chapter to discuss 
the results obtained. 
3.1 Characterization of PLA – Size Exclusion Chromatography (SEC) 
Molecular weight (MW) of PLA was characterized using SEC (Agilent, 1100 series) 
equipped with two detectors, ultraviolet (UV) and differential refractive index (RI) as 
outlined in Section 2.1.  
 
Figure 3 shows the calibration curve used to calculate the MW of synthesized PLA. 
  
 
 
 
 
 
 
 
 
 
 
        Figure 3 Calibration curve for determination of MW of polymers using SEC 
       The MW of the synthesized PLA was determined to be 2500 Da. 
3.2 Size and Zeta Potential of synthesized NPs 
Size measurements were done using a Malvern Instruments’ Zeta-Sizer Nano device. 
The dispersant refractive index was specified as that of water at 25°C. In order to 
avoid the effect of THF in the latexes on the diffractive properties of the dispersant, 
each sample was diluted ten times with de-ionised water.  
17 
 
Figure 4 shows a plot of the sizes of the polymeric NPs as a function of polymer 
concentration synthesized by the MIVM setup. As can be inferred from the graph, 
with increase in concentration of the polymer weight fraction in THF, there is an 
increase of the sizes of the synthesized NPs. It is also interesting to note that with 
increase in the molecular weight of the polymer (PLA, PLA_SA and PLA HMW), for 
a particular polymer concentration, the size increases. This can be explained by the 
fact that for higher molecular weight, it is difficult to pack the longer chains closely 
enough, resulting in increase of size. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4 Plot of DLS Size (nm) of polymeric NPs vs concentration 
Although the initial aim of the study revolved around studying PLA as the model 
polymer, different polymers were sequentially investigated to study the effect on the 
release kinetics from primary particles. However, the guiding principle was to 
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synthesize NPs as small as possible and therefore the lowest concentration was only 
chosen for studies of the other polymers. 
Figure 5 illustrates the linear variation of the sizes of PLA NPs and concentration. As 
the underlying motive of the study was to synthesize NCs from primary NPs, the 
extreme points viz. PLA0.1 and PLA0.75 were selected for further studies. 
 
 
 
 
 
 
 
 
 
 
 
Figure 5 Plot of Size (nm) of PLA NPs vs concentration 
The same instrument was also used for the measurement of the zeta potential and 
Smoluchowski model was used to process the data.  
Figure 6 shows the variation of zeta potential of various polymeric NPs with 
concentration. As can be inferred from the results, for a particular polymer, increase in 
concentration results in higher absolute zeta potential. For PLA, the negative zeta 
potential is due to the presence of carboxylic chain end groups, which during polymer 
precipitation redistribute on the NP surfaces. At lower concentrations, there are 
smaller number of carboxylic groups which can re-distribute, leading to lower zeta 
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potentials and lower colloidal stability. This effect increases with increase in 
concentration. 
 
 
 
 
 
 
 
 
 
 
 
Figure 6 Plot of Zeta potential (mV) of Polymeric NPs vs concentration 
It is also worth mentioning that for a particular polymer concentration, the absolute 
values of the zeta potentials of PCL-COOH, PCL-MPEG and the blend PCL-
COOH/MPEG decrease owing to the insertion of uncharged PEG into the polymer 
backbone. The absolute zeta potential of PLGA is higher than for PLA NPs at the 
same concentrations. Thus, PLGA NPs have higher colloidal stability than PLA NPs 
prepared from polymer solutions at same concentrations.   
Figure 7 illustrates the linear variation of the zeta potential of PLA NPs and 
concentration. As the underlying motive of the study was to synthesize NCs from 
primary NPs, the extreme points viz. PLA0.1 and PLA0.75 were selected for further 
studies. 
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Figure 7 Plot of Zeta potential (mV) of PLA NPs vs concentration 
Table 2 illustrates the measured sizes of the synthesized primary PLA NPs before and 
after solvent (THF) removal. 
Concentration of PLA  
(wt. %) 
Average Diameter (nm) Average Diameter(nm) 
after THF removal 
0.10 49.7 ± 0.4 44.9± 0.1 
0.75 155.3 ± 2.1 145.9 ± 2.0 
Table 2 Comparison of PLA NP sizes before and after removal of THF 
The subsequent decrease in the sizes of the NPs after THF removal could be 
accounted to the mechanism of THF removal. It is believed from previous 
experiments in the same line that the NP formation in the MIVM cannot be explained 
through the classical nucleation theory. Instead, after mixing, the organic phase is 
dispersed in the form of droplets into the non-solvent and precipitation occurs when 
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the solubility limit of polymer into the organic phase is reached. An indirect support 
to the droplet mechanism has also been reported previously in Fabio’s PhD thesis. 
3.3 Drug loading and Encapsulation efficiencies  
As elaborated previously, the HPLC column was calibrated using different weights of 
ibuprofen dissolved in THF. Figure 8 shows the calibration curve for the same. The 
drug was eluted around 5 minute while the THF was eluted around 7.5 minute. 
     
 
 
 
 
 
 
 
 
 
 
Figure 8 HPLC Calibration curve for ibuprofen 
As an initial check to the fact that the ibuprofen used for encapsulation was loaded 
into the NPs, preliminary experiments were performed as outlined below. After the 
formation of the drug loaded NPs using the MIVM, both the solvents viz water and 
THF were removed using a rotary evaporator and the residue was re-dissolved in THF 
(volume of THF being used to mimic the initial concentration of the PLA and 
ibuprofen dissolved in THF before the MIVM process). Figure 9 shows a comparison 
of the chromatograms obtained for this sample (in blue) and the one for the initial 
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sample before entering the MIVM setup (in red). The green curve is the 
chromatogram for pure THF. As can be observed, the coincidence of the 
chromatograms closes the mass balance and is suggestive of the fact that there is 
essentially no drug loss in the preparation technique. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9 Comparison of chromatograms 
Table 3 shows the LE and EE values of ibuprofen loaded PLA NPs synthesized from 
two different PLA concentrations in THF viz 0.1 and 0.75 wt%. As reflected in green, 
the optimum initial drug amount was selected to be 5mg per 50mg of the polymer 
solution. For initial drug concentrations above this, free drug particles were formed in 
the mixer, confirmed by bi-modal distribution in DLS studies of the samples. It is also 
reflected in EE values greater than 100% for 0.1PLA, indicating that there is not 
enough polymer particles to entrap the drugs.  
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Table 3 Drug loading efficiencies (LE %) and Encapsulation efficiencies (EE %) of 
PLA NPs loaded     with different drug amounts 
Another interesting observation is the similar LE values for both the samples, 
indicating that drug loading is independent of initial concentration of the polymer but 
rather dependent on the nature of the drug and the drug loaded NP preparation 
method employed. This will be further discussed while comparing LE and EE values 
for different polymeric NPs. 
Figure 10 shows the LE values for different polymeric NPs, the initial concentration 
of the polymer in each case being 0.1wt% except for PLGA for which it is 0.25wt% ( 
as stable NPs could not be obtained below this concentration) and the measurement 
temperature being 25°C. It is evident from the graph that high values of drug loading 
are obtained irrespective of the nature of the polymer ranging between 75% and 88%.  
 
 
 
 
Sample name Drug loading efficiency (%) 
LE 
Encapsulation efficiency (%) 
EE 
PLA0.1ibu1 82.47 1.65 
PLA0.1ibu5 87.90 8.79 
PLA0.1ibu25 94.33 47.17 
PLA0.1ibu125 98.78 246.95 
PLA0.75ibu1 88.41 0.24 
PLA0.75ibu5 89.37 1.19 
PLA0.75ibu25 95.96 6.40 
PLA0.75ibu125 98.52 32.84 
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Figure 10 Comparison of drug loading efficiencies (%) of polymeric NPs at 25°C 
Figure 11 shows the EE values for different polymeric NPs, the initial concentration 
of the polymer in each case being 0.1wt% except for PLGA for which it is 0.25wt% 
and the measurement temperature being 25°C. As reported previously, the higher 
drug loading trend is also followed in case of encapsulation efficiencies except for 
PLGA. This can be explained by the fact that initial weight of PLGA in solution is 
higher than for PLA and PCL polymers and therefore lower drug encapsulation per 
weight of polymer. 
The values when compared to those reported in literature [19-21] are comparatively 
higher for both LE and EE. This is a remarkable advantage of the MIVM setup for 
synthesizing NPs loaded with drugs. 
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Figure 11 Comparison of encapsulation efficiencies (%) of polymeric NPs at 25°C 
In order to re-check the calculated EE values and the veracity of the use of the right 
MWCO filters, two different sets of experiments were performed. 
In the first case, ultracentrifugation was applied for the 0.1PLA NPs loaded with 
ibuprofen sample to precipitate the NPs loaded with ibuprofen from the supernatant. 
Ultracentrifugation was carried out using 12ml of the stock solution and at two 
different centrifugation velocities, viz 15,000 rpm for 1 hour and 41,000 rpm for half 
an hour. In both cases, the supernatant was analyzed using the HPLC technique 
outlined in Section 2.4. The EE values for both the cases were obtained to be 93%, 
slightly higher than the ones obtained under similar conditions while using centrifugal 
filters. However, this difference is within experimental errors and is a proof of the 
fact that the technique employed (centrifugal filtration) in separating the NP-loaded 
with ibuprofen from the solution containing free/released ibuprofen is well justified. 
26 
 
In the second case, a lower MWCO centrifugal filter viz 30k was used instead of the 
standard 100k filter with all other experimental conditions being kept unchanged. The 
EE values were obtained to be the same, thereby confirming the judicious selection of 
the MWCO of the centrifugal filters. 
Thus, it is concluded that the centrifugal filtration method employing 100K MWCO 
used for separating the ibuprofen loaded NPs from the free drug in solution is well 
substantiated by the control experiments discussed previously. This technique of 
sampling has been rarely used in drug release kinetics measurement in contrast to the 
dialysis setup as reported more often in the literature [22-23]. It is however 
emphasized that this centrifugal separation technique is simpler and equally 
dependable. 
3.4 In vitro release measurements 
 
This section illustrates the release kinetics measurements from various polymeric 
NPs.  
 
Figure 12 shows the ibuprofen release profiles for different PLA NPs and also the 
effect of temperature on release of ibuprofen from PLA. As can be observed, the 
release kinetics from all the different PLA samples were extremely slow and it was 
not possible to release the entire entrapped drug. Further, a steady state value is 
reached for each sample which is also observable for higher temperatures. It is 
observed that ibuprofen release from higher molecular weight PLA (PLA HMW) is 
even slower than from lower molecular weight PLA.  This effect is also observed for 
PLA_SA and PLA at 37°C. However, this effect could also be attributed to the fact 
that while PLA_SA is a commercial sample, PLA was synthesized in house and 
differences in chemical composition of the polymers cannot be completely neglected. 
 
The effect of temperature on the release kinetics is self-explanatory. With an increase 
in the temperature, the drug diffusion coefficient (D) increases, leading to faster 
release. An estimate of the D using equation 3.1, where t represents the characteristic 
time scale and R represents the radius of the NPs, is found to be 1E-21, almost 7 
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orders of magnitude lower than reported in literature for ibuprofen release from 
micro-spheres[19]. 
          (3.1) 
 
 The glass transition temperature (Tg) of PLA varies from 52-55°C [24] depending 
upon molecular weight, synthesis method and other factors. So, the use of 
temperatures below the Tg ensures the crystallinity of the PLA. However, it is not just 
to conclude on the crystallinity of the polymer without conducting further microscopy 
studies. Moreover, it is impractical to design drug delivery vectors at temperatures 
above normal body temperature of 37°C as they cannot be rendered for real life 
applications. Thus, investigation into the temperature effect was carried out only to 
show that indeed ibuprofen is being released, but at extremely slow rates. 
 
 
 
 
 
 
 
 
 
 
 Figure 12 Comparison of Ibuprofen release kinetics from various PLA NPs and 
effect of temperature on release kinetics. 
Figure 13 presents the release kinetics measurements of ibuprofen from PCL-COOH 
NPs at different temperatures [Figure 13 (a)] and from differently functionalized PCL 
NPs at room temperature[Figure 13 (b)]. The temperature effect in the case of PCL-
COOH NPs is similar to the one observed for PLA. However, the steady state values 
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of cumulative percentage drug released obtained for PCL-COOH are much lower 
than that for PLA. Unlike PLA, PCL has a lower Tg (~-70°C) [25] and thus the release 
is from amorphous polymeric NPs. 
On the other hand, changing the functionalities from negatively charged COOH 
group to neutral PEG or even using a blend of the two does not modify the release 
kinetics profile of ibuprofen. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13 Comparison of Ibuprofen release kinetics from (a) PCL-COOH NPs at different 
temperatures (b) various PCL NPs at room temperature 
From these preliminary experiments, it was concluded that the slow release kinetics 
could be either due to a chemical interaction between the drug ibuprofen and the 
polymer, or the fact that ibuprofen is not that a good drug for release kinetics studies 
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from PLA NPs or even the fact that MIVM setup is not a suitable method. Although, 
the latter has shown the potential of loading extremely high amounts of drug into the 
NPs and could therefore be used for coating or even permanent loading of materials 
into NPs, but it may not be the best method when it comes to synthesize drug loaded 
delivery vectors which requires substantial release of the loaded material over time.  
Systematic investigation into the causes required an elaborate workplan. However, it 
was possible to investigate whether the nature of the polymer is a causative drawback. 
As depicted in Figure 14, commercial PLA and PLGA were used to synthesize NPs 
loaded with drugs. It is observed that their release profiles are comparable to release 
kinetics from PLA synthesized in house. In actuality, the release profiles from 
commercial polymeric NPs are even slower, which could be because of different 
synthesis techniques of the polymers. 
One step ahead, the effect of solvent was also checked. Instead of THF, acetone and 
acetonitrile were used for commercial PLA and PLGA respectively. There was no 
significant change in release kinetics. 
Another possibility to investigate was the location of the drug. As reported in 
literature [19-21], drug loading experiments have always been carried out for larger 
NPs extending upto micro spheres using emulsification techniques for synthesis. In 
almost all the cases, experimentalists have used one or more surfactants for synthesis 
of drug-loaded NPs. While the use of surfactants has always been reasoned as 
stabilization of emulsions, its interaction with a hydrophobic drug molecule can never 
be ruled out completely. In order to check if the use of surfactants does change the 
morphology of the drug-loaded NPs, 0.1 wt% Tween 80 solution was used instead of 
the water stream in the MIVM setup, other conditions remaining the same. However, 
there was no effect observed in the release kinetics.  
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Figure 14 Comparison of Ibuprofen release kinetics from various Polymeric NPs and 
Polymeric nano capsules 
As an alternative to the use of surfactants, a new method was implemented in order to 
form nano-capsules to decrease the distance of drug diffusion. Based on the method 
reported by Marchisio et al (http://dx.doi.org/10.1016/j.ces.2012.02.050) for the 
synthesis of nano-capsules in a very recent publication, Ethyl acetate (EA) was used 
(1.26 times the mass of polymer) in the solvent stream. The guiding principle being to 
locate the drug on the outside of the NPs as the EA forms a core in the centre and 
ibuprofen being hydrophobic would tend to stay with the polymer on the outside. The 
presence of the polymer on the outside was confirmed by negative zeta potentials as 
reported in      Table 4. Table 4 also reports the DLS sizes of the NPs loaded with 
ibuprofen. 
As observed from the data, the NPs are larger in size when compared to those 
synthesized without EA. 
 
31 
 
 
Sample Concentration of 
PLA/PLGA 
(wt. %) 
 
Average Diameter (nm) 
after drug loading 
 
Average Zeta 
potential (mV) after 
drug loading 
PLA_SA_EA 0.10 73.8 ± 0.1 -24.3± 4.5 
PLGA_SA_EA 0.25 71.8 ± 0.1 -38.8 ± 5.8 
PLA_EA 0.10 88.2 ± 5.9 -16.5 ± 2.3 
PLA_HMW_EA 0.10 93.8 ± 8.2 -38.4 ± 1.6 
Table 4 DLS Sizes (nm) and Zeta potentials(mV) of polymeric nanocapsules 
 
The release kinetics profiles from these NPs loaded with ibuprofen are also shown in 
Figure 14. As can be seen, there is significantly fast release kinetics for the 
commercial PLA, although the steady state value is still low. On the other hand, the 
other samples show almost no release at all. However, this single set of experiments 
is not enough to draw conclusions about the method. Possibilities of changing oil to 
polymer mass ratio, solvents and other parameters could be further investigated. 
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4 Future Work 
 
The project work has revealed that the MIVM setup is capable of producing drug loaded 
NPs with very high loading efficiencies for a wide range of polymers. However, it has 
also been observed that the release kinetics of ibuprofen is extremely slow in most of the 
cases, reaching a steady state value in few days. This effect has been noted irrespective of 
the nature of the polymer, whether synthesized in house or bought commercially and also 
for polymer blends. 
Thus, it would be the focus to repeat the whole set of experiments of synthesis, drug 
loading and release kinetics measurements using a new drug having similar solubility 
limits as ibuprofen. This would also suffice the claims made regarding interaction 
between the drug and the polymer. Although, within the scope of this work, two other 
drugs namely, Lidocaine and Capsaicin have been identified to repeat these experiments. 
Different analytical protocols have to be developed to use the drugs in the future work.  
Moreover, it is felt necessary to repeat a different technique altogether namely 
emulsification method to synthesize drug loaded NPs and study the release kinetics. This 
is important to justify the usage of the MIVM method in synthesizing such constructs. 
Once this incipient problem of slow release kinetics from the NPs is solved, efforts will be 
concentrated towards making NCs either through aggregation followed by breakup, or 
self-assembly of oppositely charged NP, or aggregation driven by polyelectrolyte. In the 
final part, two different populations of NPs would be loaded with different drugs and 
synthesized into NCs, whereby having capability of releasing two drugs simultaneously 
which may also be triggered by different physical conditions.   
A schematic of the future work is presented in Figure 15. The present idea upholds the 
prospect of synthesizing NCs composed of the smallest primary NPs and compare the 
encapsulation efficiencies and release kinetics of the two. However, the same could also 
be compared to those obtained for largest size of NPs to investigate into the mechanism of 
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Figure 15 Schematic of synthesis of NCs composed of two drugs 
formation of NCs and drug location. While there exist many options to tune the drug 
release, the primary objective would be to trigger the release mechanisms using different 
stimuli – heat, pH and so on. In a further step, superparamagnetic Fe NPs or even core-
shell Fe-Au NPs may be integrated into these polymeric systems to aid magnetic or even 
optical detection. These would pave the way for synthesis of multimodal drug delivery 
vectors loaded with multiple drugs and equipped with targeting as well as imaging 
possibilities.  
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       5 Conclusion 
 
This work has primarily concentrated on the synthesis of different polymeric NPs viz 
PLA (synthesized in house as well as commercial grade), PLGA (commercial) and PCL 
(synthesized in house, having different functionalities –COOH, -PEG and their blends) 
employing flash nano-precipitation technique in a MIVM setup, previously optimized in 
the Morbidelli group at ETH. These NPs were characterized using DLS (Dynamic Light 
Scattering) and Zeta-Sizer to report the variation of the sizes and zeta potentials of the 
NPs as a function of polymer molecular weight and initial concentration of polymer. The 
MIVM setup is found to produce stable polymeric NPs as small as 50nm and as large as 
155nm depending on polymer concentration and nature of polymer. 
The lowest possible sizes of the NPs were then selected for further studies as the overall 
motivation of the work is to synthesize NCs composed of primary particles. Ibuprofen 
(model drug) was loaded into the primary NPs using the MIVM setup, following which 
drug loading, encapsulation efficiencies were measured using High Performance Liquid 
Chromatography (HPLC). The results indicate that this setup is capable of producing 
drug loaded NPs with high drug loading efficiencies varying between 75% and 88% 
differing with polymers. 
The release kinetics experiments were performed at 37°C and also studied at room 
temperature (25°C) and 45°C to evaluate the effect of temperature on release mechanism. 
The drug-loaded NPs were separated from the free drug in solution at different times 
using centrifugal filtration. The amount of drug released over time was measured by 
analyzing these supernatants using HPLC. The release kinetics from almost all the 
different types of polymeric systems were slow; lasting over several days and moreover, 
it is not possible to release the entire loaded drug. Various other alternatives including 
change of solvent, use of surfactant, use of Ethyl acetate to synthesize nano-capsules, 
whereby changing the drug location were also tried out.   
It is claimed that either the chemical interaction of the polymers with ibuprofen or the 
location of the drug inside the polymeric NPs is the potential reason for extremely slow 
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release kinetics. It is therefore suggested that further investigation is needed for the same 
system with another drug to confirm the observed behavior or even a completely different 
synthesis method for drug loaded polymeric NPs using ibuprofen to substantiate the 
observed results.   
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